Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haruo Inokuchi

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Cancer Medicine|December 20, 2022
Ten-year outcomes of whole-pelvic intensity-modulated radiation therapy for prostate cancer with regional lymph node metastasisKiyonao Nakamura, Yoshiki Norihisa, Itaru Ikeda, et al.
Scientific Reports|August 23, 2024
Derived neutrophil-to-lymphocyte ratio has the potential to predict safety and outcomes of durvalumab after chemoradiation in non-small cell lung cancerAkira Sugimoto, Hiroyasu Kaneda, Naoki Yoshimoto, et al.
International Journal of Clinical Oncology|December 24, 2018
A multi-institutional observational study on the effects of three-dimensional radiotherapy and weekly 40-mg/m<sup>2</sup> cisplatin on postoperative uterine cervical cancer patients with high-risk prognostic factorsFumiaki Isohashi, Tadao Takano, Mamiko Onuki, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Cancer Medicine|December 20, 2022
Ten-year outcomes of whole-pelvic intensity-modulated radiation therapy for prostate cancer with regional lymph node metastasisKiyonao Nakamura, Yoshiki Norihisa, Itaru Ikeda, et al.
Scientific Reports|August 23, 2024
Derived neutrophil-to-lymphocyte ratio has the potential to predict safety and outcomes of durvalumab after chemoradiation in non-small cell lung cancerAkira Sugimoto, Hiroyasu Kaneda, Naoki Yoshimoto, et al.
International Journal of Clinical Oncology|December 24, 2018
A multi-institutional observational study on the effects of three-dimensional radiotherapy and weekly 40-mg/m<sup>2</sup> cisplatin on postoperative uterine cervical cancer patients with high-risk prognostic factorsFumiaki Isohashi, Tadao Takano, Mamiko Onuki, et al.
Pageof 4